KM Pharma Calls EGM for Article Amendments and Executive Compensation Rules
-
Board resolved to call an EGM on June 23, 2026; record date May 22, 2026
-
Agenda: amend articles (reflect commercial law changes, align compensation rules), approve new executive compensation regulations, amend executive severance pay regulations
KOSDAQ Filing Information
-
Filing: Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)
-
Company: KMPHARMACEUTICAL (225430)
-
Submission: KMPHARMACEUTICAL Co.,Ltd.
-
Receipt: 05-06-2026
-
Under KRX KOSDAQ Market Division